MediMabBio, having established a subsidiary in the UK, has inaugurated its office within Oxford’s BioEscalator. This strategic move aims to strengthen research and development collaborations with esteemed UK institutions like the University of Oxford and Birmingham University. The focus lies in broadening pipeline development and facilitating technology transfers.
